R. Déporte-Féty

Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity

G. Milano, M C Etienne, Muriel Barberi‐Heyob et al. · British Journal of Cancer · 1999 · 276 citations · Full text

Medicine, Oncology, Pharmacology +13

Surface‐enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node‐negative breast cancer tumors

Gabriel Ricolleau, Catherine Guérin‐Charbonnel, Laurence Lodé et al. · PROTEOMICS · 2006 · 94 citations

Life Sciences, Biochemistry, Oncology +17

Population pharmacokinetics of topotecan: intraindividual variability in total drug

Ashraf Montazeri, M. Boucaud, François Lokiec et al. · Cancer Chemotherapy and Pharmacology · 2000 · 42 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer

Jean‐Yves Douillard, Jaafar Bennouna, Fabienne Vavasseur et al. · Cancer Immunology Immunotherapy · 2000 · 31 citations · Full text

Medicine, Oncology, Pharmacology +10

Individual adaptive dosing of topotecan in ovarian cancer.

Ashraf Montazeri, Stéphane Culine, Brigitte Laguerre et al. · PubMed · 2002 · 27 citations

Medicine, Oncology, Pharmacology +17